Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 May;22(5):1238-45.
doi: 10.1002/oby.20625. Epub 2013 Dec 3.

Hepatic insulin clearance is the primary determinant of insulin sensitivity in the normal dog

Affiliations

Hepatic insulin clearance is the primary determinant of insulin sensitivity in the normal dog

Marilyn Ader et al. Obesity (Silver Spring). 2014 May.

Abstract

Objective: Insulin resistance is a powerful risk factor for Type 2 diabetes and a constellation of chronic diseases, and is most commonly associated with obesity. We examined if factors other than obesity are more substantial predictors of insulin sensitivity under baseline, nonstimulated conditions.

Methods: Metabolic assessment was performed in healthy dogs (n = 90). Whole-body sensitivity from euglycemic clamps (SICLAMP ) was the primary outcome variable, and was measured independently by IVGTT (n = 36). Adiposity was measured by MRI (n = 90), and glucose-stimulated insulin response was measured from hyperglycemic clamp or IVGTT (n = 86 and 36, respectively).

Results: SICLAMP was highly variable (5.9-75.9 dl/min per kg per μU/ml). Despite narrow range of body weight (mean, 28.7 ± 0.3 kg), adiposity varied approximately eight-fold and was inversely correlated with SICLAMP (P < 0.025). SICLAMP was negatively associated with fasting insulin, but most strongly associated with insulin clearance. Clearance was the dominant factor associated with sensitivity (r = 0.53, P < 0.00001), whether calculated from clamp or IVGTT.

Conclusions: These data suggest that insulin clearance contributes substantially to insulin sensitivity, and may be pivotal in understanding the pathogenesis of insulin resistance. We propose the hyperinsulinemia due to reduction in insulin clearance is responsible for insulin resistance secondary to changes in body weight.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Variability in adiposity and body weight in normal dogs
(A) dogs ranked by total adiposity (height of stacked bars), with respective visceral (solid) and subcutaneous (hatched) fat mass. (B) Body weight for dogs ranked by total fat. Note that variability of total and subcutaneous fat greatly exceeds that of body weight.
Figure 2
Figure 2. Correlation between clamp-based insulin sensitivity and fasting insulin under baseline conditions
Fasting insulin was inversely correlated with SICLAMP, which confirms that insulinemia may well contribute to the prevailing degree of insulin sensitivity, even in the absence of dietary or pharmacologic perturbation.
Figure 3
Figure 3. Strong correlation between insulin sensitivity and metabolic clearance rate of insulin using indices derived from (A) euglycemic hyperinsulinemic clamp and (B) IVGTT
Regardless of experimental methodology, a lower degree of insulin sensitivity was associated with low insulin clearance, which contributes to the hyperinsulinemia required as compensation for insulin resistance.

References

    1. Watanabe RM. The genetics of insulin resistance: where's Waldo? Curr Diab Rep. 2010;10:476–484. - PMC - PubMed
    1. Hollenbeck C, Reaven GM. Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance. J Clin Endocrinol Metab. 1987;64:1169–1173. - PubMed
    1. Mittelman SD, van Citters GW, Kim SP, Davis DA, Dea MK, Bergman RN. The longitudinal compensation for fat induced insulin resistance includes reduced insulin clearance and enhanced B-cell response. Diabetes. 2000;49:2116–2125. - PubMed
    1. Erdmann J, Kallabis B, Oppel U, Sypchenko O, Wagenpfeil S, Schusdziarra V. Development of hyperinsulinemia and insulin resistance during the early stage of weight gain. Am J Physiol. 2008;294:E568–E575. - PubMed
    1. Ader M, Kim SP, Catalano KC, Ionut V, Hucking K, Richey JM, et al. Metabolic dysregulation with atypical antipsychotics occurs in the absence of underlying disease: placebo-controlled study of olanzapine and risperidone in dogs. Diabetes. 2005;54:862–871. - PubMed

Publication types

LinkOut - more resources